|
|
Article: British Journal of Cancer Reports Findings by Long Beach Memorial Medical Center Physician That Identify Promising Therapy for Recurrent Breast Cancer; Todd Cancer Institute Seeks Recurrent Breast Cancer Patients For Research Trial.
- Article from:
- PR Newswire
- Article date:
- November 12, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
LONG BEACH, Calif., Nov. 12 /PRNewswire/ -- The just released November issue of British Journal of Cancer reports a study involving programmed cell death using the drug Topotecan (now used to treat ovarian and small cell lung cancers) as a promising treatment for patients with recurrent breast cancer.
The study, "Ex Vivo Analysis of Topotecan: Advancing the Application of Laboratory-Based Clinical Therapeutics," is based on research led by Robert Nagourney, M.D., medical director of Long Beach Memorial Medical Center's Todd Cancer Institute. Renowned as a medical oncologist and researcher, he's known for his pioneering work in individualized cancer therapies ...